The Prior Study
Start date:June 2017 End date:
August 2017 Co-ordinated by:
EMERGE, RIE Main trial site:
RIE
Fluid exchange is an area where more research is required, in particular the role of pore size and membrane osmotic pressure (MOP). The main objective of this study is to plot the MOP and Mean arterial pressure (MAP) of healthy participants onto a chart that has been created from previous work. This chart could act as a diagnostic tool to give individualised treatment to patients in shock. The secondary objectives are to see if it is possible to calculate MOP from biochemistry results and to create a chart plotting pore size against MOP.
This is an observational study looking to recruit 20 ‘healthy’ participants from staff employed at the RIE. Two blood samples will be taken. One sample will be sent to the labs for biochemistry testing. The second sample will be retained in order to measure MOP. Participant information taken would be minimal but include blood pressure reading and past medical history. No follow-up will be required.
Chief Investigator
Dr Gareth Clegg
Senior Lecturer at the University of Edinburgh & Honorary Consultant in Emergency Medicine
Research Team
Dr Frank Prior PhD
Pharmacist
Allan MacRaild
Stroke Lead Research Nurse
Related news
The Prior Study
19 Jul 2017 | Allan MacRaild
EMERGE and RRG are undertaking a preliminary study into the principles of fluid exchange within the body.
Read moreMore EMERGE Trials
TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.
TARGET-CTCA Trial
Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.
IONA Study
Identification of Novel Psychoactive Substances (IONA)